MCMCB Pro
M1187

M1187Patients with a diagnosis of end stage renal disease (esrd)

HCPCSActiveBETOS Z2

M1187 is a HCPCS Level II code for patients with a diagnosis of end stage renal disease (esrd). It belongs to the Medical Services section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Carrier judgment

Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusM

Measurement code. Used for reporting purposes only; never paid.

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

The CMS record for M1187

Long descriptor
Patients with a diagnosis of end stage renal disease (esrd)

The official wording. This is what the code means.

Short descriptor
Pt w/ esrd

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 2023

When CMS introduced the code.

BETOS
Z2

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
00 — Not priced by Part B

Service not separately priced by Part B — not covered, bundled into another service, or used by Part A only.

Codes adjacent to M1187

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If M1187 is not quite right, the correct code is very often within a few positions of it.

  • M1179Patient did not receive any pneumococcal conjugate or polysaccharide vaccine, on or after their 19th birthday and before or during measurement period
  • M1180Patients on immune checkpoint inhibitor therapy
  • M1181Grade 2 or above diarrhea and/or grade 2 or above colitis
  • M1182Patients not eligible due to pre-existing inflammatory bowel disease (ibd) (e.g., ulcerative colitis, crohn's disease)
  • M1183Documentation of immune checkpoint inhibitor therapy held and corticosteroids or immunosuppressants prescribed or administered
  • M1184Documentation of medical reason(s) for not prescribing or administering corticosteroid or immunosuppressant treatment (e.g., allergy, intolerance, infectious etiology, pancreatic insufficiency, hyperthyroidism, prior bowel surgical interventions, celiac disease, receiving other medication, awaiting diagnostic workup results for alternative etiologies, other medical reasons/contraindication)
  • M1185Documentation of immune checkpoint inhibitor therapy not held and/or corticosteroids or immunosuppressants prescribed or administered was not performed, reason not given
  • M1186Patients who have an order for or are receiving hospice or palliative care
  • M1188Patients with a diagnosis of chronic kidney disease (ckd) stage 5
  • M1189Documentation of a kidney health evaluation defined by an estimated glomerular filtration rate (egfr) and urine albumin-creatinine ratio (uacr) performed
  • M1190Documentation of a kidney health evaluation was not performed or defined by an estimated glomerular filtration rate (egfr) and urine albumin-creatinine ratio (uacr)
  • M1191Hospice services provided to patient any time during the measurement period
  • M1192Patients with an existing diagnosis of squamous cell carcinoma of the esophagus
  • M1193Surgical pathology reports that contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both
  • M1194Documentation of medical reason(s) surgical pathology reports did not contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both tests were not included (e.g., patient will not be treated with checkpoint inhibitor therapy, no residual carcinoma is present in the sample [tissue exhausted or status post neoadjuvant treatment], insufficient tumor for testing)
  • M1195Surgical pathology reports that do not contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both, reason not given

Questions about M1187

What is HCPCS code M1187?

M1187 is a HCPCS Level II code for patients with a diagnosis of end stage renal disease (esrd). It sits in the Medical Services section.

Does Medicare cover M1187?

The CMS HCPCS file marks M1187 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

How is M1187 paid under the physician fee schedule?

M1187 carries PFS status code M. Measurement code. Used for reporting purposes only; never paid.

HCPCS Level II2026Q3-Jul· effective July 1, 2026